You are here: Home
Treating Cancer with Light

Treating Cancer with Light

New LED Device May Help Advance Photodynamic Therapy for Skin Cancer. Scientists at the University of California, Irvine (UC Irvine), believe so. They're explo...

Exploring Opportunities in Chemical Biology

Interview with: Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann – La Roche
Drug discovery scientists need to broaden their approaches to pharmaceutical...

Maximising Drug Discovery Research

Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB
"Drug discovery scientists should focus on the biological relevance of their candidate molec...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

Serious safety concerns around unlicensed ocular bevacizumab use versus

  Recently announced results from two-year CATT (Comparison of Age-related macular degeneration Treatment Trials) adds to the growing body of evidence, including CATT 1-year data and two retrospective database analyses, suggesting

Wednesday, 2 May 2012 Comments

Press Releases

Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare

Biogen Idec Inc. announced today that its presentation at the Deutsche Bank 37th Annual Healthcare Conference will be webcast live on Tuesday, May 8, 2012 at 10:00 a.m. ET.

Thursday, 3 May 2012 Comments

Research Insight

Warfarin and aspirin are similar in heart failure treatment

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according

Monday, 6 February 2012 Comments

Techno Trends

Medicago to develop new VLP vaccine candidate for

Medicago, a biotechnology company, has completed initial studies towards the development of a new VLP vaccine candidate for ra

Friday, 20 January 2012 Comments

Industry Reports

Pfizer reports first-quarter 2012

Pfizer Inc. today reported financial results for first-quarter 2012. First-quarter 2012 revenues were $15.4 billion, a decrease of 7% compared with $16.5 billion in the year-ago quarter, which reflects an op

Tuesday, 1 May 2012 Comments

Articles

Why streamlining pharma supply chain is

For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts. But an additional – and less obvious – challenge is also ready to derail

Wednesday, 18 May 2011 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

Antares, Watson Pharmaceuticals launch Gelnique 3% in

Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bl

Friday, 27 April 2012 Comments

Production & Manufacturing

Natco Pharma wins license to manufacture, sell Nexavar in

The Indian patents office has awarded a license to Natco Pharma to manufacture and sell a generic version of Bayer's cancer treatment drug Ne

Tuesday, 13 March 2012 Comments

Packaging & Labelling

Almac Pharma Services expands packaging operations in

Almac Pharma Services business unit has expanded its established commercial packaging operations with a $10m investment in a new 100,000sq ft commercial facility in Audubon, PA, US

Thursday, 8 March 2012 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Thursday, 21 April 2011 Comments

Clinical Trials

Peregrine reports results from phase II front-line lung cancer

Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed to determine overall response rate of carboplatin and paclitaxel with or without bavituximab in 86 patients wi

Monday, 12 March 2012 Comments

IT & Data Management

Virginia adopts national precursor log exchange

The commonwealth of Virginia has adopted a real-time, stop-sale technology known as national precursor log exchange sy

Monday, 12 March 2012 Comments

Banner